234 related articles for article (PubMed ID: 31261673)
1. Latest Advances in the Development of Eukaryotic Vaults as Targeted Drug Delivery Systems.
Muñoz-Juan A; Carreño A; Mendoza R; Corchero JL
Pharmaceutics; 2019 Jun; 11(7):. PubMed ID: 31261673
[TBL] [Abstract][Full Text] [Related]
2. All-in-one biofabrication and loading of recombinant vaults in human cells.
Martín F; Carreño A; Mendoza R; Caruana P; Rodriguez F; Bravo M; Benito A; Ferrer-Miralles N; Céspedes MV; Corchero JL
Biofabrication; 2022 Mar; 14(2):. PubMed ID: 35203066
[TBL] [Abstract][Full Text] [Related]
3.
Fernández R; Carreño A; Mendoza R; Benito A; Ferrer-Miralles N; Céspedes MV; Corchero JL
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555185
[TBL] [Abstract][Full Text] [Related]
4. Vaults are dynamically unconstrained cytoplasmic nanoparticles capable of half vault exchange.
Yang J; Kickhoefer VA; Ng BC; Gopal A; Bentolila LA; John S; Tolbert SH; Rome LH
ACS Nano; 2010 Dec; 4(12):7229-40. PubMed ID: 21121616
[TBL] [Abstract][Full Text] [Related]
5. Targeting vault nanoparticles to specific cell surface receptors.
Kickhoefer VA; Han M; Raval-Fernandes S; Poderycki MJ; Moniz RJ; Vaccari D; Silvestry M; Stewart PL; Kelly KA; Rome LH
ACS Nano; 2009 Jan; 3(1):27-36. PubMed ID: 19206245
[TBL] [Abstract][Full Text] [Related]
6. Bioengineered vaults: self-assembling protein shell-lipophilic core nanoparticles for drug delivery.
Buehler DC; Marsden MD; Shen S; Toso DB; Wu X; Loo JA; Zhou ZH; Kickhoefer VA; Wender PA; Zack JA; Rome LH
ACS Nano; 2014 Aug; 8(8):7723-32. PubMed ID: 25061969
[TBL] [Abstract][Full Text] [Related]
7. Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP.
Mikyas Y; Makabi M; Raval-Fernandes S; Harrington L; Kickhoefer VA; Rome LH; Stewart PL
J Mol Biol; 2004 Nov; 344(1):91-105. PubMed ID: 15504404
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and assembly of human vault particles in yeast.
Wang M; Kickhoefer VA; Rome LH; Foellmer OK; Mahendra S
Biotechnol Bioeng; 2018 Dec; 115(12):2941-2950. PubMed ID: 30171681
[TBL] [Abstract][Full Text] [Related]
9. Immobilization of recombinant vault nanoparticles on solid substrates.
Xia Y; Ramgopal Y; Li H; Shang L; Srinivas P; Kickhoefer VA; Rome LH; Preiser PR; Boey F; Zhang H; Venkatraman SS
ACS Nano; 2010 Mar; 4(3):1417-24. PubMed ID: 20146454
[TBL] [Abstract][Full Text] [Related]
10. Vaults engineered for hydrophobic drug delivery.
Buehler DC; Toso DB; Kickhoefer VA; Zhou ZH; Rome LH
Small; 2011 May; 7(10):1432-9. PubMed ID: 21506266
[TBL] [Abstract][Full Text] [Related]
11. Cellular functions of vaults and their involvement in multidrug resistance.
Steiner E; Holzmann K; Elbling L; Micksche M; Berger W
Curr Drug Targets; 2006 Aug; 7(8):923-34. PubMed ID: 16918321
[TBL] [Abstract][Full Text] [Related]
12. Vault Nanoparticles: Chemical Modifications for Imaging and Enhanced Delivery.
Benner NL; Zang X; Buehler DC; Kickhoefer VA; Rome ME; Rome LH; Wender PA
ACS Nano; 2017 Jan; 11(1):872-881. PubMed ID: 28029784
[TBL] [Abstract][Full Text] [Related]
13. Vault nanoparticles engineered with the protein transduction domain, TAT48, enhances cellular uptake.
Yang J; Srinivasan A; Sun Y; Mrazek J; Shu Z; Kickhoefer VA; Rome LH
Integr Biol (Camb); 2013 Jan; 5(1):151-8. PubMed ID: 22785558
[TBL] [Abstract][Full Text] [Related]
14. Vaults: a ribonucleoprotein particle involved in drug resistance?
Mossink MH; van Zon A; Scheper RJ; Sonneveld P; Wiemer EA
Oncogene; 2003 Oct; 22(47):7458-67. PubMed ID: 14576851
[TBL] [Abstract][Full Text] [Related]
15. Smart vaults: thermally-responsive protein nanocapsules.
Matsumoto NM; Prabhakaran P; Rome LH; Maynard HD
ACS Nano; 2013 Jan; 7(1):867-74. PubMed ID: 23259767
[TBL] [Abstract][Full Text] [Related]
16. MVP and vaults: a role in the radiation response.
Lara PC; Pruschy M; Zimmermann M; Henríquez-Hernández LA
Radiat Oncol; 2011 Oct; 6():148. PubMed ID: 22040803
[TBL] [Abstract][Full Text] [Related]
17. Structural stability of vault particles.
Esfandiary R; Kickhoefer VA; Rome LH; Joshi SB; Middaugh CR
J Pharm Sci; 2009 Apr; 98(4):1376-86. PubMed ID: 18683860
[TBL] [Abstract][Full Text] [Related]
18. Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm.
Han M; Kickhoefer VA; Nemerow GR; Rome LH
ACS Nano; 2011 Aug; 5(8):6128-37. PubMed ID: 21740042
[TBL] [Abstract][Full Text] [Related]
19. The formation of vault-tubes: a dynamic interaction between vaults and vault PARP.
van Zon A; Mossink MH; Schoester M; Houtsmuller AB; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
J Cell Sci; 2003 Nov; 116(Pt 21):4391-400. PubMed ID: 13130096
[TBL] [Abstract][Full Text] [Related]
20. Recombinant major vault protein is targeted to neuritic tips of PC12 cells.
Herrmann C; Golkaramnay E; Inman E; Rome L; Volknandt W
J Cell Biol; 1999 Mar; 144(6):1163-72. PubMed ID: 10087261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
